Switzerland has approved Moderna’s COVID-19 vaccine for children aged 6 to 11 years, according to Swissmedic, the country’s surveillance authority for medicines and medical devices.
Moderna’s Spikevax COVID-19 vaccine will be administered to the children in two half-doses of 50 micrograms each at an interval of four weeks, Swissmedic said in a news release dated May 13. Older children and adults receive full doses of 100 micrograms.
